Development and regulation of opioid public meeting.

Ended Awarded Last action

Contract number
HHSF22314010
Awardee
Awarding agency
Obligated
$39,029

Award facts

Contract value 100% obligated
$39,029.12 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
561920 Convention and Trade Show Organizers
PSC
R708 Support- Management: Public Relations
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a BPA call to The Nakamoto Group, Inc., a woman-owned small disadvantaged business, on September 11, 2014, with a ceiling value of $39,029.12 under a total small business set-aside. The call covers development and regulation of an opioid public meeting, with performance in Silver Spring, Maryland and an ultimate completion date of November 30, 2014. Pricing is firm fixed price.

Quick answers

Who was awarded contract HHSF22314010?

HHSF22314010 was awarded to The Nakamoto Group, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 11, 2014.

How much is contract HHSF22314010 worth?

The government has obligated $39,029 on HHSF22314010.

Is contract HHSF22314010 an order under another contract?

Yes. HHSF22314010 is a BPA call under GS07F0448U-HHSF223201110009B, a blanket purchase agreement.

Was contract HHSF22314010 competed?

The extent of competition for HHSF22314010 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award